341 related articles for article (PubMed ID: 36628248)
1. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment.
He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S
Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248
[TBL] [Abstract][Full Text] [Related]
2. Revealing the novel autophagy-related genes for ligamentum flavum hypertrophy in patients and mice model.
Li P; Fei CS; Chen YL; Chen ZS; Lai ZM; Tan RQ; Yu YP; Xiang X; Dong JL; Zhang JX; Wang L; Zhang ZM
Front Immunol; 2022; 13():973799. PubMed ID: 36275675
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
4. Immune cell infiltration and the genes associated with ligamentum flavum hypertrophy: Identification and validation.
Duan Y; Ni S; Zhao K; Qian J; Hu X
Front Cell Dev Biol; 2022; 10():914781. PubMed ID: 36036007
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension.
Gao G; Chen A; Gong J; Lin W; Wu W; Mohammad Ismail Hajary S; Lian G; Luo L; Xie L
Front Genet; 2023; 14():1222368. PubMed ID: 37732317
[TBL] [Abstract][Full Text] [Related]
6. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J
Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640
[TBL] [Abstract][Full Text] [Related]
7. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease.
Li Z; Song Y; Wang M; Shen R; Qin K; Zhang Y; Jiang T; Chi Y
Front Cardiovasc Med; 2022; 9():905737. PubMed ID: 36093132
[TBL] [Abstract][Full Text] [Related]
8. ADAM10 promotes the proliferation of ligamentum flavum cells by activating the PI3K/AKT pathway.
Pan B; Huo T; Cao M; Jing L; Luo X; Qu Z; Feng H; Yuan F; Guo K
Int J Mol Med; 2021 Feb; 47(2):688-698. PubMed ID: 33416124
[TBL] [Abstract][Full Text] [Related]
9. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss.
Huo J; Chen Q; Zhang Y; Li N; Fu Z; Ma N; Zheng N; Cui N; Li L
Front Genet; 2022; 13():925652. PubMed ID: 36118846
[TBL] [Abstract][Full Text] [Related]
12. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm.
Li S; Zhang Q; Weng L; Han Y; Li J
Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129
[TBL] [Abstract][Full Text] [Related]
13. Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis.
Zhang B; Yuan L; Chen G; Chen X; Yang X; Fan T; Sun C; Fan D; Chen Z
Front Endocrinol (Lausanne); 2022; 13():861567. PubMed ID: 35712246
[TBL] [Abstract][Full Text] [Related]
14. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer.
Mu LX; Shao YC; Wei L; Chen FF; Zhang JW
Front Genet; 2021; 12():650499. PubMed ID: 35095993
[No Abstract] [Full Text] [Related]
17. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
Front Neurol; 2022; 13():889141. PubMed ID: 35989938
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
19. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy.
Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J
Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353
[TBL] [Abstract][Full Text] [Related]
20. A bioinformatics analysis of the contribution of m6A methylation to the occurrence of diabetes mellitus.
Lei L; Bai YH; Jiang HY; He T; Li M; Wang JP
Endocr Connect; 2021 Oct; 10(10):1253-1265. PubMed ID: 34486983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
